Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

One NASDAQ - Listed Automobiles Stock at Resistance Level: TSLA

May 15, 2025 | Team Kalkine
One NASDAQ - Listed Automobiles Stock at Resistance Level: TSLA
Image source: shutterstock

  • TSLA:NASDAQ
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Tesla, Inc. (NASDAQ: TSLA)

Tesla, Inc. (NASDAQ: TSLA) designs, develops, manufactures, sells and leases high-performance fully electric vehicles and energy generation and storage systems, and offers services related to its products. As per our previous US Dailies report published on ‘TSLA’ on 13th Feb 2025, Kalkine provided a ‘Buystance on the stock at USD 336.51 based on fundamental analysis and the stock price has now moved up by ~3.32%.

Noted below are the details of support and resistance levels provided in our previous report:

TSLA’s Daily Chart

 

Considering the current trading levels, risks associated, and volatile market conditions on the back of higher interest rates, an ‘Sell’ rating is assigned to the ‘TSLA’ at the close price of USD 347.68 as of May 14, 2025.

Note: This report may be updated with details around fundamental and technical analysis, price chart in due course, as appropriate.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is May 14, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.


Disclaimer-

Disclosure: Any research report published by Kalkine New Zealand Limited with respect to Tesla, Inc. will contain a disclosure in the report: "Kalkine New Zealand Limited's (Kalkine) director Kunal Sawhney owns shares of Tesla, Inc. since March 2024. Kalkine has recommended Tesla, Inc. in its report as general advice only (under FSP Number FSP691351). The advice given by Kalkine is provided for general informational purposes and should not be considered as personalized investment advice. Investors should conduct their own research and seek professional advice before making any investment decisions."

This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.